Provided by Tiger Trade Technology Pte. Ltd.

Arvinas Holding Company LLC

9.37
+0.34003.77%
Post-market: 9.370.00000.00%19:30 EDT
Volume:951.75K
Turnover:8.84M
Market Cap:612.34M
PE:70.06
High:9.39
Open:9.02
Low:9.00
Close:9.03
52wk High:14.51
52wk Low:6.97
Shares:65.39M
Float Shares:56.67M
Volume Ratio:1.77
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1337
EPS(LYR):-1.1400
ROE:1.59%
ROA:-1.01%
PB:1.09
PE(LYR):-8.21

Loading ...

Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
May 12

Arvinas Q1 Basic EPS USD -0.9

THOMSON REUTERS
·
May 12

Arvinas Q1 Net Income USD -57.6 Million VS. Ibes Estimate USD -61.5 Million

THOMSON REUTERS
·
May 12

Rigel licenses breast cancer drug VEPPANU from Arvinas, Pfizer for USD 70 million

Reuters
·
May 12

Arvinas Inc - and Pfizer to Receive $85 Mln in Upfront and Transition Payments

THOMSON REUTERS
·
May 12

Arvinas Inc - and Pfizer Eligible for up to $320 Mln in Milestone Payments and Tiered Royalties

THOMSON REUTERS
·
May 12

Arvinas and Pfizer Enter Into a Transaction With Rigel Pharmaceuticals for the Exclusive Global Rights of Veppanu (Vepdegestrant)

THOMSON REUTERS
·
May 12

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

GlobeNewswire
·
May 12

Arvinas Q1 net loss widens to $57.6 million; revenue drops 91.74% to $15.6 million

Reuters
·
May 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 11

Arvinas Inc expected to post a loss of 92 cents a share - Earnings Preview

Reuters
·
May 08

Arvinas to webcast first-quarter 2026 results, corporate update

Reuters
·
May 05

Arvinas Is Maintained at Buy by Citigroup

Dow Jones
·
May 05

FDA approves Guardant360 CDx as companion diagnostic for Pfizer-Arvinas VEPPANU

Reuters
·
May 04

Guggenheim Remains a Buy on Arvinas Holding Company (ARVN)

TIPRANKS
·
May 04

Arvinas price target raised to $24 from $21 at Citi

TIPRANKS
·
May 04

Arvinas Holding Company (ARVN) Gets a Buy from Barclays

TIPRANKS
·
May 04

BUZZ-U.S. STOCKS ON THE MOVE-Perella Weinberg Partners, Amkor Technology, Esperion Therapeutics

Reuters
·
May 02

Arvinas gets early approval for Vepdeg, says Truist

TIPRANKS
·
May 02

Arvinas announces FDA approval of VEPPANU for ESR1m, ER+/HER2- ABC

TIPRANKS
·
May 02